Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Apolipoprotein B Particles and Cardiovascular Disease

Allan D. Sniderman, George Thanassoulis, Tamara Glavinovic, Ann Marie Návar, Michael Pencina, Alberico L. Catapano, Brian A. Ference

JAMA Cardiology · 2019

Read source ↗ All evidence

Summary

Importance: The conventional model of atherosclerosis presumes that the mass of cholesterol within very low-density lipoprotein particles, low-density lipoprotein particles, chylomicron, and lipoprotein (a) particles in plasma is the principal determinant of the mass of cholesterol that will be deposited within the arterial wall and will drive atherogenesis. However, each of these particles contains one molecule of apolipoprotein B (apoB) and there is now substantial evidence that apoB more accurately measures the atherogenic risk owing to the apoB lipoproteins than does low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol. Observations: Cholesterol can only enter the arterial wall within apoB particles. However, the mass of cholesterol per apoB particle is varia

Source type
Peer-reviewed study
DOI
10.1001/jamacardio.2019.3780
Catalogue ID
SNmoj444w8-76aria
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.